NCT01582880View on ClinicalTrials.gov

Use of Cross-linked Donor Corneas as Carriers for the Boston Keratoprosthesis

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

1

Participants

Timeline

Start Date

March 31, 2012

Primary Completion Date

March 31, 2014

Study Completion Date

March 31, 2014

Conditions
Chemical InjuriesUnspecified Complication of Corneal TransplantAutoimmune DiseasesOcular Cicatricial PemphigoidStevens Johnson SyndromeLupus Erythematosus, SystemicRheumatoid ArthritisOther Autoimmune Diseases
Interventions
DRUG

Riboflavin

Used to treat donor cornea before implantation

Trial Locations (1)

02114

Massachusetts Eye and Ear Infirmary, Boston

All Listed Sponsors
lead

Joseph B. Ciolino, MD

OTHER

NCT01582880 - Use of Cross-linked Donor Corneas as Carriers for the Boston Keratoprosthesis | Biotech Hunter | Biotech Hunter